Clinical Trials Logo

Ruptured Intracranial Aneurysm clinical trials

View clinical trials related to Ruptured Intracranial Aneurysm.

Filter by:
  • None
  • Page 1

NCT ID: NCT02056574 Withdrawn - Clinical trials for Subarachnoid Hemorrhage

Safety and Efficacy Study of a Single Dose of NA-1 in Patients Undergoing Endovascular Repair of Ruptured Aneurysms

ENACT-2
Start date: November 2015
Phase: Phase 2
Study type: Interventional

This is a randomized, double-blind, placebo-controlled, single-dose study investigating the safety and efficacy of NA-1 in patients with subarachnoid hemorrhage (SAH) undergoing endovascular repair of ruptured intracranial aneurysms. Up to 300 male and female patients with SAH undergoing endovascular repair of a ruptured intracranial aneurysm will be dosed with 2.60 mg/kg of NA-1 or placebo as a 10 minute intravenous infusion after completion of the endovascular procedure on Day 1 of the study period. Subjects will undergo interim procedures at Day 2-4, Day 30-45, and end-of-study procedures on Day 90.